A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death throughout the world. Due to the shortcomings of traditional chemotherapy, targeted therapies have come into prominence for the management of NSCLC. In particular, epidermal growth factor receptor (EGFR) tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Özdemir, Ahmet, Ciftci, Halilibrahim, Sever, Belgin, Tateishi, Hiroshi, Otsuka, Masami, Fujita, Mikako, Altıntop, Mehlika Dilek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778314/
https://www.ncbi.nlm.nih.gov/pubmed/35056800
http://dx.doi.org/10.3390/molecules27020485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778314/
https://www.ncbi.nlm.nih.gov/pubmed/35056800
http://dx.doi.org/10.3390/molecules27020485

Ejemplares similares